Global Liposomal Drug-delivery System Market Research Report 2025(Status and Outlook)

March 2025 | 253 pages | ID: GD96F9D2A6BFEN
Bosson Research

Abstracts

Report Overview

Liposomal Drug-delivery System is a pharmaceutical technology that encapsulates drugs within lipid-based vesicles called liposomes. These microscopic structures enhance the delivery of drugs to target tissues, improve drug stability, and control drug release rates. Liposomal drug delivery is used to enhance the therapeutic effects of medications, reduce side effects, and improve the solubility of poorly water-soluble drugs.

This report provides a deep insight into the global Liposomal Drug-delivery System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liposomal Drug-delivery System Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liposomal Drug-delivery System market in any manner.

Global Liposomal Drug-delivery System Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Lipoid Kosmetik

Lucas Meyer Cosmetics

Nippon Fine Chemical

Enoc Solutions

Nanovec

Lipotec

Croda

H&A Pharmachem

Lipomize

ID bio

BioSpectrum

Derma Clinical

Kewpie Corporation

Nanohealth Biotech

Creative Biostructure

Phenbiox

NOF CORPORATION

KYOWA PHARMA CHEMICAL

Nikko Chemicals

Market Segmentation (by Type)

Liposome Vitamin

Liposome Ceramide

Liposome CoQ10

Others

Market Segmentation (by Application)

Medical

Cosmetics

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Liposomal Drug-delivery System Market
• Overview of the regional outlook of the Liposomal Drug-delivery System Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liposomal Drug-delivery System Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Liposomal Drug-delivery System
1.2 Key Market Segments
  1.2.1 Liposomal Drug-delivery System Segment by Type
  1.2.2 Liposomal Drug-delivery System Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Liposomal Drug-delivery System Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Liposomal Drug-delivery System Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Liposomal Drug-delivery System Product Life Cycle
3.3 Global Liposomal Drug-delivery System Sales by Manufacturers (2020-2025)
3.4 Global Liposomal Drug-delivery System Revenue Market Share by Manufacturers (2020-2025)
3.5 Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Liposomal Drug-delivery System Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Liposomal Drug-delivery System Manufacturing Sites, Area Served, Product Type
3.8 Liposomal Drug-delivery System Market Competitive Situation and Trends
  3.8.1 Liposomal Drug-delivery System Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Liposomal Drug-delivery System Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 LIPOSOMAL DRUG-DELIVERY SYSTEM INDUSTRY CHAIN ANALYSIS

4.1 Liposomal Drug-delivery System Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Liposomal Drug-delivery System Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Liposomal Drug-delivery System Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET BY REGION

6.1 Global Liposomal Drug-delivery System Market Size by Region
  6.1.1 Global Liposomal Drug-delivery System Market Size by Region
  6.1.2 Global Liposomal Drug-delivery System Market Size Market Share by Region
6.2 Global Liposomal Drug-delivery System Sales by Region
  6.2.1 Global Liposomal Drug-delivery System Sales by Region
  6.2.2 Global Liposomal Drug-delivery System Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Liposomal Drug-delivery System Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Liposomal Drug-delivery System Market Size by Type
7.3 North America Liposomal Drug-delivery System Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Liposomal Drug-delivery System Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Liposomal Drug-delivery System Market Size by Type
8.3 Europe Liposomal Drug-delivery System Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Liposomal Drug-delivery System Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Liposomal Drug-delivery System Market Size by Type
9.3 Asia-Pacific Liposomal Drug-delivery System Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Liposomal Drug-delivery System Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Liposomal Drug-delivery System Market Size by Type
10.3 South America Liposomal Drug-delivery System Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Liposomal Drug-delivery System Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Liposomal Drug-delivery System Market Size by Type
11.3 Middle East and Africa Liposomal Drug-delivery System Market Size by Application

12 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET PRODUCTION BY REGION

12.1 Global Production of Liposomal Drug-delivery System by Region(2020-2025)
12.2 Global Liposomal Drug-delivery System Revenue Market Share by Region (2020-2025)
12.3 Global Liposomal Drug-delivery System Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Liposomal Drug-delivery System Production
  12.4.1 North America Liposomal Drug-delivery System Production Growth Rate (2020-2025)
  12.4.2 North America Liposomal Drug-delivery System Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Liposomal Drug-delivery System Production
  12.5.1 Europe Liposomal Drug-delivery System Production Growth Rate (2020-2025)
  12.5.2 Europe Liposomal Drug-delivery System Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Liposomal Drug-delivery System Production (2020-2025)
  12.6.1 Japan Liposomal Drug-delivery System Production Growth Rate (2020-2025)
  12.6.2 Japan Liposomal Drug-delivery System Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Liposomal Drug-delivery System Production (2020-2025)
  12.7.1 China Liposomal Drug-delivery System Production Growth Rate (2020-2025)
  12.7.2 China Liposomal Drug-delivery System Production, Revenue, Price and Gross Margin (2020-2025)

13 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Liposomal Drug-delivery System Sales Market Share by Type (2020-2033)
13.3 Global Liposomal Drug-delivery System Market Size Market Share by Type (2020-2033)
13.4 Global Liposomal Drug-delivery System Price by Type (2020-2033)

14 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Liposomal Drug-delivery System Market Sales by Application (2020-2033)
14.3 Global Liposomal Drug-delivery System Market Size (M USD) by Application (2020-2033)
14.4 Global Liposomal Drug-delivery System Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Lipoid Kosmetik
  15.1.1 Lipoid Kosmetik Basic Information
  15.1.2 Lipoid Kosmetik Liposomal Drug-delivery System Product Overview
  15.1.3 Lipoid Kosmetik Liposomal Drug-delivery System Product Market Performance
  15.1.4 Lipoid Kosmetik Business Overview
  15.1.5 Lipoid Kosmetik SWOT Analysis
  15.1.6 Lipoid Kosmetik Recent Developments
15.2 Lucas Meyer Cosmetics
  15.2.1 Lucas Meyer Cosmetics Basic Information
  15.2.2 Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Overview
  15.2.3 Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Market Performance
  15.2.4 Lucas Meyer Cosmetics Business Overview
  15.2.5 Lucas Meyer Cosmetics SWOT Analysis
  15.2.6 Lucas Meyer Cosmetics Recent Developments
15.3 Nippon Fine Chemical
  15.3.1 Nippon Fine Chemical Basic Information
  15.3.2 Nippon Fine Chemical Liposomal Drug-delivery System Product Overview
  15.3.3 Nippon Fine Chemical Liposomal Drug-delivery System Product Market Performance
  15.3.4 Nippon Fine Chemical Business Overview
  15.3.5 Nippon Fine Chemical SWOT Analysis
  15.3.6 Nippon Fine Chemical Recent Developments
15.4 Enoc Solutions
  15.4.1 Enoc Solutions Basic Information
  15.4.2 Enoc Solutions Liposomal Drug-delivery System Product Overview
  15.4.3 Enoc Solutions Liposomal Drug-delivery System Product Market Performance
  15.4.4 Enoc Solutions Business Overview
  15.4.5 Enoc Solutions Recent Developments
15.5 Nanovec
  15.5.1 Nanovec Basic Information
  15.5.2 Nanovec Liposomal Drug-delivery System Product Overview
  15.5.3 Nanovec Liposomal Drug-delivery System Product Market Performance
  15.5.4 Nanovec Business Overview
  15.5.5 Nanovec Recent Developments
15.6 Lipotec
  15.6.1 Lipotec Basic Information
  15.6.2 Lipotec Liposomal Drug-delivery System Product Overview
  15.6.3 Lipotec Liposomal Drug-delivery System Product Market Performance
  15.6.4 Lipotec Business Overview
  15.6.5 Lipotec Recent Developments
15.7 Croda
  15.7.1 Croda Basic Information
  15.7.2 Croda Liposomal Drug-delivery System Product Overview
  15.7.3 Croda Liposomal Drug-delivery System Product Market Performance
  15.7.4 Croda Business Overview
  15.7.5 Croda Recent Developments
15.8 HandA Pharmachem
  15.8.1 HandA Pharmachem Basic Information
  15.8.2 HandA Pharmachem Liposomal Drug-delivery System Product Overview
  15.8.3 HandA Pharmachem Liposomal Drug-delivery System Product Market Performance
  15.8.4 HandA Pharmachem Business Overview
  15.8.5 HandA Pharmachem Recent Developments
15.9 Lipomize
  15.9.1 Lipomize Basic Information
  15.9.2 Lipomize Liposomal Drug-delivery System Product Overview
  15.9.3 Lipomize Liposomal Drug-delivery System Product Market Performance
  15.9.4 Lipomize Business Overview
  15.9.5 Lipomize Recent Developments
15.10 ID bio
  15.10.1 ID bio Basic Information
  15.10.2 ID bio Liposomal Drug-delivery System Product Overview
  15.10.3 ID bio Liposomal Drug-delivery System Product Market Performance
  15.10.4 ID bio Business Overview
  15.10.5 ID bio Recent Developments
15.11 BioSpectrum
  15.11.1 BioSpectrum Basic Information
  15.11.2 BioSpectrum Liposomal Drug-delivery System Product Overview
  15.11.3 BioSpectrum Liposomal Drug-delivery System Product Market Performance
  15.11.4 BioSpectrum Business Overview
  15.11.5 BioSpectrum Recent Developments
15.12 Derma Clinical
  15.12.1 Derma Clinical Basic Information
  15.12.2 Derma Clinical Liposomal Drug-delivery System Product Overview
  15.12.3 Derma Clinical Liposomal Drug-delivery System Product Market Performance
  15.12.4 Derma Clinical Business Overview
  15.12.5 Derma Clinical Recent Developments
15.13 Kewpie Corporation
  15.13.1 Kewpie Corporation Basic Information
  15.13.2 Kewpie Corporation Liposomal Drug-delivery System Product Overview
  15.13.3 Kewpie Corporation Liposomal Drug-delivery System Product Market Performance
  15.13.4 Kewpie Corporation Business Overview
  15.13.5 Kewpie Corporation Recent Developments
15.14 Nanohealth Biotech
  15.14.1 Nanohealth Biotech Basic Information
  15.14.2 Nanohealth Biotech Liposomal Drug-delivery System Product Overview
  15.14.3 Nanohealth Biotech Liposomal Drug-delivery System Product Market Performance
  15.14.4 Nanohealth Biotech Business Overview
  15.14.5 Nanohealth Biotech Recent Developments
15.15 Creative Biostructure
  15.15.1 Creative Biostructure Basic Information
  15.15.2 Creative Biostructure Liposomal Drug-delivery System Product Overview
  15.15.3 Creative Biostructure Liposomal Drug-delivery System Product Market Performance
  15.15.4 Creative Biostructure Business Overview
  15.15.5 Creative Biostructure Recent Developments
15.16 Phenbiox
  15.16.1 Phenbiox Basic Information
  15.16.2 Phenbiox Liposomal Drug-delivery System Product Overview
  15.16.3 Phenbiox Liposomal Drug-delivery System Product Market Performance
  15.16.4 Phenbiox Business Overview
  15.16.5 Phenbiox Recent Developments
15.17 NOF CORPORATION
  15.17.1 NOF CORPORATION Basic Information
  15.17.2 NOF CORPORATION Liposomal Drug-delivery System Product Overview
  15.17.3 NOF CORPORATION Liposomal Drug-delivery System Product Market Performance
  15.17.4 NOF CORPORATION Business Overview
  15.17.5 NOF CORPORATION Recent Developments
15.18 KYOWA PHARMA CHEMICAL
  15.18.1 KYOWA PHARMA CHEMICAL Basic Information
  15.18.2 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Overview
  15.18.3 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Market Performance
  15.18.4 KYOWA PHARMA CHEMICAL Business Overview
  15.18.5 KYOWA PHARMA CHEMICAL Recent Developments
15.19 Nikko Chemicals
  15.19.1 Nikko Chemicals Basic Information
  15.19.2 Nikko Chemicals Liposomal Drug-delivery System Product Overview
  15.19.3 Nikko Chemicals Liposomal Drug-delivery System Product Market Performance
  15.19.4 Nikko Chemicals Business Overview
  15.19.5 Nikko Chemicals Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Liposomal Drug-delivery System Market Size by Type (M USD)
Table 4. Global Liposomal Drug-delivery System Market Size by Application (M USD)
Table 5. Liposomal Drug-delivery System Market Size Comparison by Region (M USD)
Table 6. Global Liposomal Drug-delivery System Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Liposomal Drug-delivery System Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Liposomal Drug-delivery System Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Liposomal Drug-delivery System Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug-delivery System as of 2024)
Table 11. Global Market Liposomal Drug-delivery System Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Liposomal Drug-delivery System Manufacturing Sites and Area Served
Table 13. Manufacturers Liposomal Drug-delivery System Product Type
Table 14. Global Liposomal Drug-delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Liposomal Drug-delivery System Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Liposomal Drug-delivery System Market Size Comparison by Region (M USD)
Table 26. Global Liposomal Drug-delivery System Market Size by Region (2020-2033) & (M USD)
Table 27. Global Liposomal Drug-delivery System Market Size Market Share by Region (2020-2033)
Table 28. Global Liposomal Drug-delivery System Sales by Region (2020-2033) & (K MT)
Table 29. Global Liposomal Drug-delivery System Sales Market Share by Region (2020-2033)
Table 30. North America Liposomal Drug-delivery System Market Size by Country (2020-2033) & (M USD)
Table 31. North America Liposomal Drug-delivery System Sales by Country (2020-2033) & (K MT)
Table 32. North America Liposomal Drug-delivery System Sales by Type (K MT)
Table 33. North America Liposomal Drug-delivery System Market Size by Type (M USD)
Table 34. North America Liposomal Drug-delivery System Sales (K MT) by Type (2020-2033)
Table 35. North America Liposomal Drug-delivery System Market Size (M USD) by Type (2020-2033)
Table 36. North America Liposomal Drug-delivery System Sales by Application (K MT)
Table 37. North America Liposomal Drug-delivery System Market Size by Application (M USD)
Table 38. North America Liposomal Drug-delivery System Sales (K MT) by Application (2020-2033)
Table 39. North America Liposomal Drug-delivery System Market Size (M USD) by Application (2020-2033)
Table 40. Europe Liposomal Drug-delivery System Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Liposomal Drug-delivery System Sales by Country (2020-2033) & (K MT)
Table 42. Europe Liposomal Drug-delivery System Sales by Type (K MT)
Table 43. Europe Liposomal Drug-delivery System Market Size by Type (M USD)
Table 44. Europe Liposomal Drug-delivery System Sales (K MT) by Type (2020-2033)
Table 45. Europe Liposomal Drug-delivery System Market Size (M USD) by Type (2020-2033)
Table 46. Europe Liposomal Drug-delivery System Sales by Application (K MT)
Table 47. Europe Liposomal Drug-delivery System Market Size by Application (M USD)
Table 48. Europe Liposomal Drug-delivery System Sales (K MT) by Application (2020-2033)
Table 49. Europe Liposomal Drug-delivery System Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Liposomal Drug-delivery System Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Liposomal Drug-delivery System Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Liposomal Drug-delivery System Sales by Type (K MT)
Table 53. Asia-Pacific Liposomal Drug-delivery System Market Size by Type (M USD)
Table 54. Asia-Pacific Liposomal Drug-delivery System Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Liposomal Drug-delivery System Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Liposomal Drug-delivery System Sales by Application (K MT)
Table 57. Asia-Pacific Liposomal Drug-delivery System Market Size by Application (M USD)
Table 58. Asia-Pacific Liposomal Drug-delivery System Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Liposomal Drug-delivery System Market Size (M USD) by Application (2020-2025)
Table 60. South America Liposomal Drug-delivery System Market Size by Country (2020-2033) & (M USD)
Table 61. South America Liposomal Drug-delivery System Sales by Country (2020-2033) & (K MT)
Table 62. South America Liposomal Drug-delivery System Sales by Type (K MT)
Table 63. South America Liposomal Drug-delivery System Market Size by Type (M USD)
Table 64. South America Liposomal Drug-delivery System Sales (K MT) by Type (2020-2033)
Table 65. South America Liposomal Drug-delivery System Market Size (M USD) by Type (2020-2033)
Table 66. South America Liposomal Drug-delivery System Sales by Application (K MT)
Table 67. South America Liposomal Drug-delivery System Market Size by Application (M USD)
Table 68. South America Liposomal Drug-delivery System Sales (K MT) by Application (2020-2033)
Table 69. South America Liposomal Drug-delivery System Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Liposomal Drug-delivery System Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Liposomal Drug-delivery System Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Liposomal Drug-delivery System Sales by Type (K MT)
Table 73. Middle East and Africa Liposomal Drug-delivery System Market Size by Type (M USD)
Table 74. Middle East and Africa Liposomal Drug-delivery System Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Liposomal Drug-delivery System Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Liposomal Drug-delivery System Sales by Application (K MT)
Table 77. Middle East and Africa Liposomal Drug-delivery System Market Size by Application (M USD)
Table 78. Middle East and Africa Liposomal Drug-delivery System Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Liposomal Drug-delivery System Market Size (M USD) by Application (2020-2033)
Table 80. Global Liposomal Drug-delivery System Production (K MT) by Region(2020-2025)
Table 81. Global Liposomal Drug-delivery System Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Liposomal Drug-delivery System Revenue Market Share by Region (2020-2025)
Table 83. Global Liposomal Drug-delivery System Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Liposomal Drug-delivery System Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Liposomal Drug-delivery System Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Liposomal Drug-delivery System Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Liposomal Drug-delivery System Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Liposomal Drug-delivery System Sales by Type (K MT)
Table 89. Global Liposomal Drug-delivery System Market Size by Type (M USD)
Table 90. Global Liposomal Drug-delivery System Sales (K MT) by Type (2020-2033)
Table 91. Global Liposomal Drug-delivery System Sales Market Share by Type (2020-2033)
Table 92. Global Liposomal Drug-delivery System Market Size (M USD) by Type (2020-2033)
Table 93. Global Liposomal Drug-delivery System Market Size Share by Type (2020-2033)
Table 94. Global Liposomal Drug-delivery System Sales (K MT) by Application
Table 95. Global Liposomal Drug-delivery System Market Size by Application(M USD)
Table 96. Global Liposomal Drug-delivery System Sales by Application (2020-2033) & (K MT)
Table 97. Global Liposomal Drug-delivery System Sales Market Share by Application (2020-2033)
Table 98. Global Liposomal Drug-delivery System Market Size by Application (2020-2033) & (M USD)
Table 99. Global Liposomal Drug-delivery System Market Share by Application (2020-2033)
Table 100. Global Liposomal Drug-delivery System Sales Growth Rate by Application (2020-2033)
Table 101. Lipoid Kosmetik Basic Information
Table 102. Lipoid Kosmetik Liposomal Drug-delivery System Product Overview
Table 103. Lipoid Kosmetik Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Lipoid Kosmetik Business Overview
Table 105. Lipoid Kosmetik SWOT Analysis
Table 106. Lipoid Kosmetik Recent Developments
Table 107. Lucas Meyer Cosmetics Basic Information
Table 108. Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Overview
Table 109. Lucas Meyer Cosmetics Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Lucas Meyer Cosmetics Business Overview
Table 111. Lucas Meyer Cosmetics SWOT Analysis
Table 112. Lucas Meyer Cosmetics Recent Developments
Table 113. Nippon Fine Chemical Basic Information
Table 114. Nippon Fine Chemical Liposomal Drug-delivery System Product Overview
Table 115. Nippon Fine Chemical Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Nippon Fine Chemical Business Overview
Table 117. Nippon Fine Chemical SWOT Analysis
Table 118. Nippon Fine Chemical Recent Developments
Table 119. Enoc Solutions Basic Information
Table 120. Enoc Solutions Liposomal Drug-delivery System Product Overview
Table 121. Enoc Solutions Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Enoc Solutions Business Overview
Table 123. Enoc Solutions Recent Developments
Table 124. Nanovec Basic Information
Table 125. Nanovec Liposomal Drug-delivery System Product Overview
Table 126. Nanovec Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Nanovec Business Overview
Table 128. Nanovec Recent Developments
Table 129. Lipotec Basic Information
Table 130. Lipotec Liposomal Drug-delivery System Product Overview
Table 131. Lipotec Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Lipotec Business Overview
Table 133. Lipotec Recent Developments
Table 134. Croda Basic Information
Table 135. Croda Liposomal Drug-delivery System Product Overview
Table 136. Croda Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Croda Business Overview
Table 138. Croda Recent Developments
Table 139. HandA Pharmachem Basic Information
Table 140. HandA Pharmachem Liposomal Drug-delivery System Product Overview
Table 141. HandA Pharmachem Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. HandA Pharmachem Business Overview
Table 143. HandA Pharmachem Recent Developments
Table 144. Lipomize Basic Information
Table 145. Lipomize Liposomal Drug-delivery System Product Overview
Table 146. Lipomize Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Lipomize Business Overview
Table 148. Lipomize Recent Developments
Table 149. ID bio Basic Information
Table 150. ID bio Liposomal Drug-delivery System Product Overview
Table 151. ID bio Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. ID bio Business Overview
Table 153. ID bio Recent Developments
Table 154. BioSpectrum Basic Information
Table 155. BioSpectrum Liposomal Drug-delivery System Product Overview
Table 156. BioSpectrum Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. BioSpectrum Business Overview
Table 158. BioSpectrum Recent Developments
Table 159. Derma Clinical Basic Information
Table 160. Derma Clinical Liposomal Drug-delivery System Product Overview
Table 161. Derma Clinical Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Derma Clinical Business Overview
Table 163. Derma Clinical Recent Developments
Table 164. Kewpie Corporation Basic Information
Table 165. Kewpie Corporation Liposomal Drug-delivery System Product Overview
Table 166. Kewpie Corporation Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Kewpie Corporation Business Overview
Table 168. Kewpie Corporation Recent Developments
Table 169. Nanohealth Biotech Basic Information
Table 170. Nanohealth Biotech Liposomal Drug-delivery System Product Overview
Table 171. Nanohealth Biotech Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Nanohealth Biotech Business Overview
Table 173. Nanohealth Biotech Recent Developments
Table 174. Creative Biostructure Basic Information
Table 175. Creative Biostructure Liposomal Drug-delivery System Product Overview
Table 176. Creative Biostructure Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Creative Biostructure Business Overview
Table 178. Creative Biostructure Recent Developments
Table 179. Phenbiox Basic Information
Table 180. Phenbiox Liposomal Drug-delivery System Product Overview
Table 181. Phenbiox Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Phenbiox Business Overview
Table 183. Phenbiox Recent Developments
Table 184. NOF CORPORATION Basic Information
Table 185. NOF CORPORATION Liposomal Drug-delivery System Product Overview
Table 186. NOF CORPORATION Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. NOF CORPORATION Business Overview
Table 188. NOF CORPORATION Recent Developments
Table 189. KYOWA PHARMA CHEMICAL Basic Information
Table 190. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Overview
Table 191. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. KYOWA PHARMA CHEMICAL Business Overview
Table 193. KYOWA PHARMA CHEMICAL Recent Developments
Table 194. Nikko Chemicals Basic Information
Table 195. Nikko Chemicals Liposomal Drug-delivery System Product Overview
Table 196. Nikko Chemicals Liposomal Drug-delivery System Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Nikko Chemicals Business Overview
Table 198. Nikko Chemicals Recent Developments
List of Figures
Figure 1. Product Picture of Liposomal Drug-delivery System
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liposomal Drug-delivery System Market Size (M USD), 2024-2033
Figure 5. Global Liposomal Drug-delivery System Market Size (M USD) (2020-2033)
Figure 6. Global Liposomal Drug-delivery System Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liposomal Drug-delivery System Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Liposomal Drug-delivery System Product Life Cycle
Figure 13. Liposomal Drug-delivery System Sales Share by Manufacturers in 2024
Figure 14. Global Liposomal Drug-delivery System Revenue Share by Manufacturers in 2024
Figure 15. Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Liposomal Drug-delivery System Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Liposomal Drug-delivery System Revenue in 2024
Figure 18. Industry Chain Map of Liposomal Drug-delivery System
Figure 19. Global Liposomal Drug-delivery System Market PEST Analysis
Figure 20. Global Liposomal Drug-delivery System Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Liposomal Drug-delivery System Market Size by Region
Figure 27. Global Liposomal Drug-delivery System Market Size Market Share by Region (2020-2033)
Figure 28. Global Liposomal Drug-delivery System Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Liposomal Drug-delivery System Market Size (M USD) by Country
Figure 33. USA Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Liposomal Drug-delivery System Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Liposomal Drug-delivery System Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Liposomal Drug-delivery System Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Liposomal Drug-delivery System Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Liposomal Drug-delivery System Market Size (M USD)by Type
Figure 40. North America Liposomal Drug-delivery System Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Liposomal Drug-delivery System Market Size (M USD) by Country
Figure 45. Germany Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Liposomal Drug-delivery System Market Size (M USD) by Type
Figure 56. Europe Liposomal Drug-delivery System Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Liposomal Drug-delivery System Market Size (M USD) by Country
Figure 61. China Liposomal Drug-delivery System Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Liposomal Drug-delivery System Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Liposomal Drug-delivery System Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Liposomal Drug-delivery System Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Liposomal Drug-delivery System Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Liposomal Drug-delivery System Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Liposomal Drug-delivery System Market Size (M USD) by Type
Figure 72. Asia-Pacific Liposomal Drug-delivery System Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Liposomal Drug-delivery System Market Size (M USD) by Country
Figure 77. Brazil Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Liposomal Drug-delivery System Market Size (M USD) by Type
Figure 84. South America Liposomal Drug-delivery System Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Liposomal Drug-delivery System Market Size (M USD) by Country
Figure 89. Saudi Arabia Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Liposomal Drug-delivery System Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Liposomal Drug-delivery System Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Liposomal Drug-delivery System Market Size (M USD) by Type
Figure 100. Middle East and Africa Liposomal Drug-delivery System Market Size (M USD) by Application
Figure 101. Global Liposomal Drug-delivery System Production Market Share by Region (2020-2025)
Figure 102. North America Liposomal Drug-delivery System Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Liposomal Drug-delivery System Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Liposomal Drug-delivery System Production (K MT) Growth Rate (2020-2025)
Figure 105. China Liposomal Drug-delivery System Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Liposomal Drug-delivery System Market Size by Type (M USD)
Figure 108. Sales Market Share of Liposomal Drug-delivery System by Type (2020-2033)
Figure 109. Sales Market Share of Liposomal Drug-delivery System by Type in 2024
Figure 110. Market Size Share of Liposomal Drug-delivery System by Type (2020-2033)
Figure 111. Market Size Share of Liposomal Drug-delivery System by Type in 2024
Figure 112. Global Liposomal Drug-delivery System Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Liposomal Drug-delivery System Market Size by Application(M USD)
Figure 115. Global Liposomal Drug-delivery System Market Share by Application
Figure 116. Global Liposomal Drug-delivery System Sales Market Share by Application (2020-2033)
Figure 117. Global Liposomal Drug-delivery System Sales Market Share by Application in 2024
Figure 118. Global Liposomal Drug-delivery System Market Share by Application (2020-2033)
Figure 119. Global Liposomal Drug-delivery System Market Share by Application in 2024
Figure 120. Global Liposomal Drug-delivery System Sales Growth Rate by Application (2020-2033)